Acer Therapeutics Inc. (ACER): Price and Financial Metrics

Acer Therapeutics Inc. (ACER): $0.66

0.14 (-17.95%)

POWR Rating

Component Grades








ACER Price/Volume Stats

Current price $0.66 52-week high $4.56
Prev. close $0.80 52-week low $0.55
Day low $0.66 Volume 574,600
Day high $0.85 Avg. volume 885,392
50-day MA $0.81 Dividend yield N/A
200-day MA $1.00 Market Cap 16.15M

ACER Stock Price Chart Interactive Chart >

Acer Therapeutics Inc. (ACER) Company Bio

Acer Therapeutics Inc., formerly Opexa Therapeutics, develops therapies for the treatment of serious ultra-rare diseases with critical unmet medical needs. The company offers Celiprolol for vascular ehlers-danlos syndrome and ACER-001 for maple syrup urine disease. It also offers advancing ACER-001 for the treatment of urea cycle disorders. The company was founded in 2013 and is based in Cambridge, Massachusetts.

ACER Latest News Stream

Event/Time News Detail
Loading, please wait...

ACER Latest Social Stream

Loading social stream, please wait...

View Full ACER Social Stream

Latest ACER News From Around the Web

Below are the latest news stories about ACER THERAPEUTICS INC that investors may wish to consider to help them evaluate ACER as an investment opportunity.

Why Is Acer Therapeutics (ACER) Stock Up 85% Today?

Acer Therapeutics (ACER) stock is taking off on Thursday after the company announced an acquisition deal with Zevra Therapeutics (ZVRA).

William White on InvestorPlace | August 31, 2023

Shopify (SHOP) Stock Jumps 6% on Amazon Deal

Shopify (SHOP) stock is on the rise Thursday as investors react to a deal between it and e-commerce giant Amazon (AMZN).

William White on InvestorPlace | August 31, 2023

Why Is Axcella Health (AXLA) Stock Down 21% Today?

Axcella Health (AXLA) stock is falling on Thursday following a rally from its announcement of a new Covid-19 treatment patent.

William White on InvestorPlace | August 31, 2023

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

It's time for another breakdown of the biggest pre-market stock movers as we dive into all of the latest news for Thursday!

William White on InvestorPlace | August 31, 2023

Struggling Newton biotech Acer Therapeutics scooped up by Florida firm

Celebration, Florida's Zevra Therapeutics Inc. is set to buy Acer Therapeutics Inc. in a deal worth up to $91 million.

Yahoo | August 31, 2023

Read More 'ACER' Stories Here

ACER Price Returns

1-mo N/A
3-mo N/A
6-mo N/A
1-year -19.49%
3-year -77.40%
5-year -96.21%
2023 0.00%
2022 10.09%
2021 -12.98%
2020 -34.66%
2019 -80.07%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!